Inhaled insulin: weighing the pros and cons.
Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy; Centre for the Study of Endocrine-Metabolic Pathophysiology and Clinical Research, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy; Laboratory of Molecular Medicine, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy. Electronic address: giuseppe.derosa@unipv.it.
Giuseppe
G
Derosa
Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy; PhD School in Experimental Medicine, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy.
Pamela
P
Maffioli
D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male
D007004:Hypoglycemic Agents; D007328:Insulin